Endoscopic treatment for post-operative fistulas of the upper digestive tract: FISTULENDO study

Aims Upper gastrointestinal cancers are common and come with a high mortality. Surgical treatment of these cancers is the cornerstone of curative care. One of the most feared surgical complications is the anastomotic fistula and its endoscopic management is a major challenge in clinical practice. The aim of this study was to evaluate the efficiency of endoscopic management of postoperative fistulas of the upper gastrointestinal tract.

Methods This was a prospective, multicenter, descriptive French study. Patients with an early fistula (< 30 days) after upper gastrointestinal surgery for cancer were included. Endoscopic management was performed based on an expert pre-determined algorithm. The primary outcome measure was clinical success (fistula healing), with no need for surgery. Fistula healing was defined as the absence of a cutaneous fistulization and CT collection 3 months after stent removal. The secondary objectives were: technical success, mortality, adverse effects, total duration of treatment, and length of hospital stay.

Results Seventy-four patients, 78.4% male, with a mean age of 64.9 years (+ /- 9.9) were included in the study. 35 patients (48.6%) had esophageal cancer, 30 patients (40.5%) had gastric cardia cancer and 9 patients (12.2%) had gastric cancer. 59 patients (79.7%) had an adenocarcinoma. 57 patients (77.0%) had a Lewis Santy procedure and 13 patients (17.6%) had a total gastrectomy. An abscess complicated the fistula in 23 patients (31.1%), with a mean size of 107.4 mm (+ /- 275.5), of which 54.2% were drained radiologically (53.8%) or surgically (46.2%). The type of anastomosis leakage was focal (< 2cm or<25% of the circumference) in 23 patients (33.8%), partial in 18 patients (26.5%), small (< 5mm) in 25 patients (36.8%) and complete in 2 patients (2.9%). Double pigtail plastic stents were placed in 13 patients (17.6%) and 24mm covered metal stents in 60 patients (81.1%). The technical success rate was 100%. The average rate of endoscopic procedures was 2.5 (1 – 5) per patient (total 182 procedures). Adverse events occurred during the procedure in 6 patients (3.3%) and post procedure in 12 patients (16.2%). Repeat surgery was needed in five patients (6.8%) due to failure of endoscopic treatment. The mean length of hospital stay was 33.9 days (+ /- 22.9). Overall mortality was 17.2% (10 patients) and 5 deaths occurred after the 3-month evaluation. No endoscopy-related death was noted. At 3-months, data was available in 65 patients (87.8%), with cutaneous fistulization in one patient and residual collection on CT in two patients. Clinical success was observed in 57 patients (87.7%), and 77.0% in intention to treat.

Conclusions In this French multicenter prospective study evaluating the endoscopic treatment of upper digestive fistulas after surgery for cancer, the clinical and technical success rates were 87.7% and 100% respectively, with an adverse event rate of 3.3%. These results are encouraging and must be confirmed by additional studies.

 

Scroll to top

Conflicts of Interest

Authors do not have any conflict of interest to disclose.

Publication History

Article published online:
27 March 2025